NEUROD1 and hepatocellular carcinoma: Knocking down NeuroD1 led to an increase in lipid ROS in HCC-LM3 and MHCC-97H cells (Figs 2D and S4A), while overexpressing NeuroD1 robustly suppressed this effect (S4B and S4C Fig).